Johnson & Johnson (JNJ) PT Raised to $201 at Leerink Partners, 'Improving Growth Prospects'
Tweet Send to a Friend
Leerink Partners analyst David Risinger raised the price target on Johnson & Johnson (NYSE: JNJ) to $201.00 (from $171.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
